Rotech Bondholders Want Baker & McKenzie Fees Capped

Law360, New York (May 15, 2013, 4:44 PM ET) -- Rotech Healthcare Inc.’s bondholders on Wednesday echoed the bankrupt medical equipment maker’s opposition to the retention of Baker & McKenzie LLP on an hourly basis as counsel for the official equity committee, saying the firm should only be compensated by a contingent fee.

Capital Research and Management Co., Fidelity Investments, Silver Point Capital LP and Venor Capital Management LP, as holders of approximately $290 million in second lien notes, said until creditors are paid in full, counsel for the equity committee should either work on a...
To view the full article, register now.

Dewey Verdict Watch

Follow our exclusive coverage of the trial of the year:

Click here for the latest